Bronchioloalveolar carcinoma in Spain: A rare and different form of lung cancer;Carcinoma bronquioloalveolar en España. Un cáncer de pulmón infrecuente y diferente

Archivos de Bronconeumologia

Volumn 42, Issue 8, 2006, Pages 399-403

  López Encuentra, Ángel ^a   Pozo Rodríguez, Francisco ^a   Martín De Nicolás, José Luis ^a   Villena, Victoria ^a   Sayas Catalán, Javier ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Bronchioloalveolar carcinoma; Lung cancer; Staging; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; FEMALE; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PREVALENCE; WEIGHT REDUCTION;

EID: 33748788545     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091649     Document Type: Article

References (27)

1. Colby TV, Noguchi M. Adenocarcinoma. En: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, editors. Tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 35-44.
2. Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279-87.
3. Miller VA, Hirsch FR, Johnson DH. Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunities. J Clin Oncol. 2005;23:3288-93.
4. Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S). Cirugía del carcinoma broncogénico en España. Estudio descriptivo. Arch Bronconeumol. 1995;31:303-9.
5. th ed. New York: Wiley-Liss; 1997. p. 91-7.
6. López Encuentra A, and the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Criteria of functional and oncological operability in surgery for lung cancer. A multicenter study. Lung Cancer. 1998;20:161-8.
7. López Encuentra A, Gómez de la Cámara A, Varela de Ugarte A, Manes N, Llobregat N y GCCB-S. El "fenómeno Will-Rogers". Migración de estadios en carcinoma broncogénico, tras aplicar criterios de certeza clasificatoria. Arch Bronconeumol. 2002;38: 166-71.
8. American Thoracic Society, Clinical staging primary lung cancer. Am Rev Respir Dis. 1983;127:659-64.
9. Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel WT, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg. 1995;59: 209-14.
10. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21: 1029-34.
11. López Encuentra A, Gómez de la Cámara A, for the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Validation of a central review board of staging prior to surgery for non-small-cell lung cancer - impact on prognosis: a multicenter study. Respiration. 2002; 69:16-24.
12. Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S). Control de calidad en un registro multiinstitucional de carcinoma broncogénico. Arch Bronconeumol. 1996;32 Supl 2:70.
13. López-Encuentra A, García Luján R, Rivas JJ, Rodríguez-Rodríguez J, Torres-Lanza J, Varela Simó G. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery Comparison between clinical and pathologic staging in 2994 cases lung cancer. Ann Thorac Surg. 2005;79:974-9.
14. Detterbeck FC, Jones DR, Funkhouser WF. Bronchioloalveolar carcinoma. En: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG, editors. Diagnosis and treatment of lung cancer. An evidence-based guide for the practicing clinician. Philadelphia: WB Saunders; 2001. p. 394-407.
15. Read WL, Page NC, Tierney RM, Piccirillo JF, Govindan R. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer. 2004;45: 137-42.
16. Wootton SK, Halbert CL, Miller AD. Sheep retrovirus structural protein induces lung tumours. Nature. 2005;434:904-7.
17. De las Heras M, Barsky SH, Hasleton P, Wagner M, Larson E, Egan J, et al. Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. Eur Respir J. 2000;16:330-2.
18. López-Encuentra A, Bulzebruck H, Feinstein AR, Motta G, Mountain CF, Naruke T, et al. Tumor staging and classification in lung cancer. Lung Cancer. 2000;29:79-83.
19. Albertine KH, Steiner RM, Radack DM, Golding DM, Peterson D, Cohn HE, et al. Analysis of cell type and radiographic presentation as predictors of the clinical course of patients with bronchioalveolar cell carcinoma. Chest. 1998;113:997-1006.
20. Dumont P, Gasser B, Rouge C, Massard G, Wihlm JM. Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients. Chest. 1998;113:391-5.
21. Daly RC, Trastek VF, Pairolero PC, Murtaugh PA, Huang MS, Allen MS, et al. Bronchoalveolar carcinoma: factors affecting survival. Ann Thorac Surg. 1991;51:368-76.
22. Okubo K, Mark EJ, Flieder D, Wain JC, Wright CD, Moncure AC, et al. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg. 1999; 118:702-9.
23. Grover FL, Piantadosi S. Recurrence and survival following resection of bronchioloalveolar carcinoma of the lung - The Lung Cancer Study Group experience. Ann Surg. 1989;209:779-90.
24. Regnard JF, Santelmo N, Romdhani N, Gharbi N, Bourcereau J, Dulmet E, et al. Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors. Chest. 1998;114:45-50.
25. Ebright MI, Zakowski MF, Martin J, Venkatraman ES, Miller VA, Bains MS, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg. 2002;74:1640-6.
26. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75:2844-52.
27. Goldstraw P. The International Staging Committee of the IASLC: its origins and purpose. Lung Cancer. 2002;37:345-8.